Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NAV26

Copy Product Info
😃Good
Catalog No. T24520Cas No. 1198160-14-3
Alias NAV-26, NAV 26

NAV26 (compound 26) is a selective voltage-gated sodium channel Nav1.7 blocker with an IC50 of 0.37 μM, and is extensively used in pain research to investigate Nav1.7-mediated nociceptive signaling, validate analgesic targets. NAV26 (compound 26) support the development of novel pain therapeutics with improved specificity and reduced central nervous system side effects.

NAV26

NAV26

Copy Product Info
😃Good
Purity: 99.93%
Catalog No. T24520Alias NAV-26, NAV 26Cas No. 1198160-14-3
NAV26 (compound 26) is a selective voltage-gated sodium channel Nav1.7 blocker with an IC50 of 0.37 μM, and is extensively used in pain research to investigate Nav1.7-mediated nociceptive signaling, validate analgesic targets. NAV26 (compound 26) support the development of novel pain therapeutics with improved specificity and reduced central nervous system side effects.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$78-In Stock
5 mg$189-In Stock
10 mg$278-In Stock
25 mg$493-In Stock
50 mg$693-In Stock
100 mg$979-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.93%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
NAV26 (compound 26) is a selective voltage-gated sodium channel Nav1.7 blocker with an IC50 of 0.37 μM, and is extensively used in pain research to investigate Nav1.7-mediated nociceptive signaling, validate analgesic targets. NAV26 (compound 26) support the development of novel pain therapeutics with improved specificity and reduced central nervous system side effects.
Targets&IC50
Nav1.7:0.37 μM
In vitro
NAV26 functions as a state-dependent blocker of NaV1.7, a channel subtype validated for pain modulation. In electrophysiological assays, it exhibits an IC₅₀ of 0.37 μM for NaV1.7 [2].
SynonymsNAV-26, NAV 26
Chemical Properties
Molecular Weight434.41
FormulaC22H21F3N2O4
Cas No.1198160-14-3
SmilesO=C1C=2C=CC=CC2C(C(=O)NCC3=CC=C(OC(F)(F)F)C=C3)N1C4CCOCC4
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (230.2 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3020 mL11.5099 mL23.0197 mL115.0986 mL
5 mM0.4604 mL2.3020 mL4.6039 mL23.0197 mL
10 mM0.2302 mL1.1510 mL2.3020 mL11.5099 mL
20 mM0.1151 mL0.5755 mL1.1510 mL5.7549 mL
50 mM0.0460 mL0.2302 mL0.4604 mL2.3020 mL
100 mM0.0230 mL0.1151 mL0.2302 mL1.1510 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NAV26 | purchase NAV26 | NAV26 cost | order NAV26 | NAV26 chemical structure | NAV26 in vitro | NAV26 formula | NAV26 molecular weight